Johnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot
a booster dose
for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot. The Food and Drug Administration could decide on J&J’s request within weeks. The agency has scheduled an Oct. 15 meeting of an advisory panel to review the evidence of the need for a booster, and to recommend whether the agency should authorize one.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Johnson & Johnson asks FDA to authorize Covid-19 vaccine booster shotsJohnson & Johnson has asked the FDA to authorize booster shots for its coronavirus vaccine, but has left it up to the FDA and the US Centers for Disease Control and Prevention to decide just who should get their boosters and when.
Baca lebih lajut »
Johnson & Johnson Seeks U.S. Clearance For COVID-19 Vaccine Booster DosesJ&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.
Baca lebih lajut »
Johnson & Johnson seeks FDA authorization of Covid booster shotJ&J said Monday that giving a second dose two months after the first increased protection against symptomatic moderate to severe Covid-19 to 94 percent, with 100 percent protection against severe illness.
Baca lebih lajut »
Johnson & Johnson files for authorization of Covid vaccine boosterThe vaccine maker said an additional second shot of its vaccine given about two months after the first increased its effectiveness to 94 percent, compared with 70 percent protection with the single dose.
Baca lebih lajut »
Covid-19 Booster Shots Win Broad Backing From European RegulatorEurope’s top health regulator issued a broad endorsement of Covid-19 vaccine booster shots, diverging from U.S. officials’ more limited recommendation
Baca lebih lajut »